SAN DIEGO--(BUSINESS WIRE)--$ERIC #attorney--The Class: Shareholder rights law firm Robbins LLP informs investors that a shareholder filed a class action on behalf of persons and entities that purchased or otherwise acquired Telefonaktiebolaget LM Ericsson (NASDAQ: ERIC) securities between April 27, 2017 and February 25, 2022, for violations of the Securities Exchange Act of 1934. Ericsson, […]
RADNOR, Pa.--(BUSINESS WIRE)--$TALK--The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Talkspace, Inc. (“Talkspace”) (NASDAQ: TALK) f/k/a Hudson Executive Investment Corporation (“HEIC”) (NASDAQ: HEC; HECCW; HECCU). The action charges Talkspace with violations of the federal securities laws, including omissions and fraudulent […]
NEW ORLEANS--(BUSINESS WIRE)--ClaimsFiler, a FREE shareholder information service, reminds investors that they have only until March 8, 2022 to file lead plaintiff applications in a securities class action lawsuit against First Solar, Inc. (NasdaqGS: FSLR), if they purchased the Company’s shares between February 22, 2019 and February 20, 2020, inclusive (the “Class Period”). This action […]
NEW ORLEANS--(BUSINESS WIRE)--ClaimsFiler, a FREE shareholder information service, reminds investors that they have only until March 7, 2022 to file lead plaintiff applications in a securities class action lawsuit against Bright Health Group, Inc. (NYSE: BHG), if they purchased the Company’s securities between June 24, 2021 and November 10, 2021, inclusive (the “Class Period”) and/or […]
NEW YORK--(BUSINESS WIRE)--#Action--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Talkspace, Inc. (“Talkspace” or the “Company”) (NASDAQ: TALK) in the United States District Court for the Southern District of New York on behalf of all persons and entities who purchased or […]
NEW YORK--(BUSINESS WIRE)--#Action--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Talis Biomedical Corporation (“Talis Biomedical” or the “Company”) (NASDAQ: TLIS) in the United States District Court for the Northern District of California on behalf of all persons and entities who purchased […]
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Exela Technologies, Inc. (NasdaqCM: XELA). On March 16, 2020, the Company disclosed that it was unable to file its Form 10-K for […]
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into ATI Physical Therapy, Inc. (NYSE: ATIP; ATIP WS) f/k/a Fortress Value Acquisition Corp. II. (NYSE: FAII; FAII WS). On February 22, 2021, […]
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into ChemoCentryx, Inc. (NasdaqGS: CCXI). On May 4, 2021, the U.S. Food and Drug Administration (the “FDA”) issued briefing documents regarding the New […]
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Cedar Realty Trust, Inc. (NYSE: CDR) and its assets in a series of related all-cash transactions. If you would like to discuss your legal rights regarding […]
Lawyer Monthly is a news website and monthly legal publication with content that is entirely defined by the significant legal news from around the world.
We use cookies to ensure that we give you the best experience on our website. By continuing to use this site you consent to the use of cookies. Privacy PolicyOkI do not consent
